Business Update

Deltex Medical new trial data show CardioQ reducing duration of hospital stays by one-third

Published in Blood Weekly, October 5th, 2006

Deltex Medical Group plc (Deltex Medical or the company), the U.K.'s leading haemodynamic monitoring company, announced the recent publication in the British Journal of Surgery of the results of a major new clinical trial using its CardioQ oesophageal Doppler monitors.

The study conducted at the Freeman Hospital in Newcastle demonstrated that in cases where doctors used Deltex Medical's CardioQ treatment during surgery to help better maintain fluid balance and blood circulation, those patients suffered fewer complications and were fit for discharge three days sooner than those who did not receive the treatment.

Specifically, the study's main...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2006-10-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry